Xyntha
Biological Hematology
NDC 58394-012-01
General payments
$45,975
Research payments
$107,530
Through program year 2025, $45,975 in general payments and $107,530 in research payments were reported against Xyntha (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $22,137 | 789 |
| 2025 | Research | $37,360 | 27 |
| 2024 | General | $6,638 | 318 |
| 2024 | Research | $14,980 | 38 |
| 2023 | General | $5,779 | 299 |
| 2023 | Research | $6,580 | 7 |
| 2022 | General | $3,995 | 216 |
| 2022 | Research | $48,610 | 25 |
| 2021 | General | $998 | 61 |
| 2020 | General | $278 | 16 |
| 2019 | General | $6,150 | 75 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,774 general · 97 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.